RADX · Radiopharm Theranostics
AI read · Good for RADX
The AI's read
Fast Track status is not FDA approval, but it marks a step in RAD101's development. Siemens' manufacturing and distribution role supports the planned U.S. Phase 3 trial. The report gives no accuracy results, so it does not show how well the scan works. The development steps still favor Radiopharm.